CGI Inc
GIB
69.00
-0.60
-0.86%
CGI Inc
US · GIB
#1173 by market cap
Listed 1970
69.00
-0.60
-0.86%
Live - 5344 symbols - heartbeat 452s ago
· 2026-10-07 19:54
After-hours
69.00
0.00%
- Market cap
- 14.29B
- P/E (TTM)i
- 12.22
- P/Bi
- 2.01
- EPSi
- 5.16
- Div yieldi
- 0.67%
- 52W posi
- 27%
Reader sentiment
Are you bullish or bearish on GIB?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Fair
- Altman Z-Score is 2.71, in the 1.8-3.0 "grey zone".
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +8.43% YoY
Margins
- Gross margin
- 16.41%
- Operating margin
- 16.41%
- Net margin
- 10.42%
Key ratios & quality
- Enterprise valuei
- 17.23B
- PEG ratioi
- 2.92
- Altman Z-Scorei
- 2.71
PEG uses trailing P/E against the 3-year net income growth rate (4.19%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 11.51B | 12.11B | 12.16B | 12.13B | 12.87B | 14.30B | 14.68B | 15.91B |
| Gross profit | 2.15B | 2.28B | 2.48B | 2.50B | 2.09B | 2.31B | 2.42B | 2.61B |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 1.71B | 1.83B | 1.88B | 1.96B | 2.09B | 2.31B | 2.42B | 2.61B |
| Pretax profit | 1.49B | 1.68B | 1.52B | 1.84B | 1.97B | 2.20B | 2.29B | 2.24B |
| Tax | 348.58M | 413.74M | 398.41M | 468.92M | 500.82M | 566.66M | 598.24M | 583.91M |
| Net profit | 1.14B | 1.26B | 1.12B | 1.37B | 1.47B | 1.63B | 1.69B | 1.66B |
| Basic EPS | 4 | 5 | 4 | 6 | 6 | 7 | 7 | 7 |
| Diluted EPS | 3.95 | 4.55 | 4.20 | 5.41 | 6.04 | 6.86 | 7.31 | 7.35 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 4.02B | 4.09B | 4.01B | 4.08B | 4.16B | 4.19B |
| Gross profit | 666.21M | 666.35M | 667.97M | 655.65M | 691.57M | 681.65M |
| Selling & admin expenses | -- | -- | -- | -- | -- | -- |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 666.21M | 666.35M | 667.97M | 655.65M | 691.57M | 681.65M |
| Pretax profit | 582.62M | 551.59M | 516.24M | 599.79M | 617.67M | 633.92M |
| Tax | 152.88M | 142.98M | 134.89M | 157.80M | 172.95M | 168.72M |
| Net profit | 429.74M | 408.61M | 381.36M | 442.00M | 444.72M | 465.20M |
| Basic EPS | 2 | 2 | 2 | 2 | 2 | 2 |
| Diluted EPS | 1.89 | 1.82 | 1.71 | 2.03 | 2.09 | 2.23 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 3.10B | 3.26B | 4.94B | 4.77B | 4.35B | 4.93B | 4.82B | 5.05B |
| Cash & ST investments | 196.49M | 253.76M | 1.73B | 1.72B | 1.00B | 1.58B | 1.46B | 867.88M |
| Inventory | 942.83M | 1.10B | 1.08B | 1.05B | 1.19B | 1.14B | 1.21B | 1.37B |
| Total assets | 11.92B | 12.62B | 15.55B | 15.02B | 15.18B | 15.80B | 16.69B | 19.52B |
| Total current liabilities | 3.12B | 2.88B | 3.66B | 3.80B | 3.65B | 4.65B | 3.55B | 5.10B |
| Short-term debt | 348.58M | 113.51M | 489.48M | 560.55M | 251.39M | 1.36B | 151.25M | 1.02B |
| Long-term debt | 1.45B | 2.22B | 3.28B | 3.01B | 3.17B | 1.94B | 2.69B | 2.79B |
| Total liabilities | 5,234,259,000.00 | 5,737,643,000.00 | 8,286,198,000.00 | 8,034,789,000.00 | 7,902,696,000.00 | 7,489,205,000.00 | 7,257,478,000.00 | 9,239,496,000.00 |
| Total equity | 6.68B | 6.88B | 7.26B | 6.99B | 7.27B | 8.31B | 9.43B | 10.28B |
| Retained earnings | 4.25B | 4.56B | 4.70B | 4.73B | 5.43B | 6.33B | 7.13B | 7.43B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 4.71B | 5.25B | 5.05B | 4.57B | 4.96B | 5.00B |
| Cash & ST investments | 1.10B | 1.13B | 867.88M | 841.10M | 716.04M | 633.42M |
| Inventory | 1.30B | 1.37B | 1.37B | 1.18B | 1.38B | 1.46B |
| Total assets | 18.72B | 19.19B | 19.52B | 18.91B | 19.30B | 19.58B |
| Total current liabilities | 3.71B | 4.12B | 5.10B | 4.87B | 5.25B | 5.35B |
| Short-term debt | 164.86M | 167.54M | 1.02B | 998.77M | 1.02B | 1.03B |
| Long-term debt | 3.70B | 3.57B | 2.79B | 2.77B | 2.80B | 2.82B |
| Total liabilities | 8,550,067,000.00 | 8,981,535,000.00 | 9,239,496,000.00 | 8,966,666,000.00 | 9,303,513,000.00 | 9,435,066,000.00 |
| Total equity | 10.17B | 10.21B | 10.28B | 9.95B | 10.00B | 10.15B |
| Retained earnings | 7.44B | 7.55B | 7.43B | 7.30B | 7.34B | 7.39B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 1.49B | 1.63B | 1.94B | 2.12B | 1.86B | 2.11B | 2.20B | 2.23B |
| Depreciation & amortization | 392.68M | 392.30M | 565.69M | 510.57M | 474.62M | 450.44M | 447.17M | 504.12M |
| Free cash flow | 1.25B | 1.37B | 1.70B | 1.88B | 1.57B | 1.81B | 1.94B | 1.96B |
| Dividends paid | -- | -- | -- | -- | -- | -- | 0 | -135.05M |
| Stock buybacks / issuance | -741.14M | -1.10B | -1.06B | -1.47B | -942.00M | -774.16M | -925.09M | -1.23B |
| Ending cash balance | 184.09M | 213.83M | 1.71B | 2.16B | 1.47B | 1.84B | 1.69B | 1.57B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 438.16M | 486.61M | 663.01M | 871.93M | 451.08M | 604.53M |
| Depreciation & amortization | 147.41M | 172.84M | 42.36M | 148.75M | 165.37M | 153.38M |
| Free cash flow | 366.20M | 410.92M | 601.67M | 808.27M | 382.43M | 532.24M |
| Dividends paid | -34.06M | -33.58M | -33.28M | -37.00M | -36.24M | -35.71M |
| Stock buybacks / issuance | -320.00M | -273.30M | -482.56M | -580.86M | -390.23M | -465.98M |
| Ending cash balance | 1.37B | 1.83B | 1.57B | 1.35B | 1.50B | 1.45B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 17.71 | 18.62 | 15.80 | 19.21 | 20.56 | 20.94 | 19.09 | 16.83 |
| ROA %i | 9.79 | 10.29 | 7.94 | 8.96 | 9.71 | 10.53 | 10.42 | 9.16 |
| ROIC %i | 14.40 | 14.75 | 11.42 | 12.61 | 13.64 | 14.30 | 13.79 | 12.53 |
| 5-year avg ROE %i | 17.55 | 17.47 | 17.10 | 17.54 | 18.38 | 19.03 | 19.12 | 19.33 |
| EBIT margin %i | 13.55 | 14.40 | 13.37 | 16.01 | 15.96 | 15.99 | 16.19 | 14.84 |
| FCF / sales %i | 10.90 | 11.28 | 13.94 | 15.50 | 12.21 | 12.63 | 13.23 | 12.34 |
| Current ratioi | 1.00 | 1.13 | 1.35 | 1.25 | 1.19 | 1.06 | 1.36 | 0.99 |
| Quick ratioi | 0.54 | 0.56 | 0.81 | 0.78 | 0.65 | 0.65 | 0.81 | 0.49 |
| Debt / assetsi | 15.11 | 18.47 | 28.70 | 27.82 | 26.20 | 23.69 | 19.83 | 22.19 |
| LT debt / equityi | 21.73 | 32.21 | 54.71 | 51.79 | 51.22 | 28.69 | 33.49 | 32.22 |
| Interest coveragei | 22.71 | 25.98 | 14.71 | 18.82 | 23.66 | 26.04 | 28.02 | 19.84 |
| Revenue CAGR (3Y) %i | 3.81 | 4.27 | 3.90 | 1.76 | 2.04 | 5.53 | 6.57 | 7.34 |
| Net income CAGR (3Y) %i | 5.30 | 5.73 | 2.59 | 6.25 | 5.09 | 13.43 | 7.33 | 4.19 |
| FCF CAGR (3Y) %i | 4.63 | 8.59 | 14.17 | 14.43 | 4.78 | 2.10 | 1.07 | 7.73 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 18.34 | 17.93 | 16.83 | 16.78 | 16.62 | 17.03 |
| ROA %i | 10.12 | 9.79 | 9.16 | 9.02 | 8.82 | 8.94 |
| ROIC %i | 13.39 | 13.27 | 12.53 | 12.61 | 12.18 | 12.56 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 16.20 | 15.57 | 14.84 | 14.68 | 14.82 | 15.23 |
| FCF / sales %i | 12.90 | 12.44 | 12.34 | 13.50 | 13.49 | 14.14 |
| Current ratioi | 1.27 | 1.27 | 0.99 | 0.94 | 0.95 | 0.93 |
| Quick ratioi | 0.70 | 0.65 | 0.49 | 0.50 | 0.44 | 0.42 |
| Debt / assetsi | 23.33 | 22.11 | 22.19 | 22.69 | 22.29 | 22.15 |
| LT debt / equityi | 41.31 | 39.93 | 32.22 | 33.10 | 32.84 | 32.58 |
| Interest coveragei | 26.70 | 23.11 | 19.84 | 18.57 | 17.73 | 18.31 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Managed information technology (IT) and business process services is the largest reported line at 55.28% of revenue, across 2 reported segments.
- Business and strategic information technology (IT) consulting and systems integration services follows at 44.72%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Managed information technology (IT) and business process services55.28%
Business and strategic information technology (IT) consulting and systems integration services44.72%
Quote time 2026-10-07 19:54:59 · For reference only, not investment advice and not tailored to your situation.